All the latest news, information on events, and other relevant opportunities – including a feature in CNN, a new job opportunity, and support for innovators applying to our Accelerator – in the March 2019 issue of our newsletter.
“What does it takes to create successful leaders in digital transformation in the NHS?” we ask, as we begin supporting the second cohort of our NHS Digital Pioneer Fellowship. We’ve found that addressing a real need within the system, finding the right participants, appropriate design, and a clear evaluation framework are key ingredients.
An NHS clinician, a business development strategist, and a communications expert give their advice to healthtech startups on what makes a good pitch. Key takeaways are: use your time wisely, use the right language for your audience, demonstrate your credibility, and look the part.
There are just a few days left to apply for the DigitalHealth.London Accelerator, which opened its doors for applications in February. We invite companies to apply by 5 April, and for the first time are accepting applications from companies outside of London and the UK.
Our flagship Accelerator programme has been featured by CNN Business as part of their “Innovative Cities” series, which shines a light on new ways that cities are tackling their unique challenges. Two Accelerator companies were highlighted as examples of how digital technologies can transform public service delivery in health.
Slides and webinars are available to support innovators through the application process to the DigitalHealth.London Accelerator. Click here to access information about the application process and criteria, and for more about what support the programme offers.
On Monday 4 March 2019 NICE published an updated version of its evidence standards framework for digital health technologies (DHTs) that sets out the evidence requirements for different types of DHTs.
Excitement building about the upcoming launch of the DigitalHealth.London 2019 Impact Report, looking back over the last 12 months and beyond.